Patient Guide: A Dose-escalation Study Followed by a Dose Optimal Study to Evaluate the Safety and Efficacy of CID-103 in Adults With Chronic Immune Thrombocytopenia

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • ✓ Get matched to the right study location for you
  • ✓ Connect directly with study coordinators at 6 participating sites
  • ✓ Understand eligibility with our simplified screening tool
  • ✓ Free service - we're here to help you access clinical research
Trial ID: NCTNCT07017725
Status: 🟢 Enrolling Now
Condition: Chronic Immune Thrombocytopenia
Phase: PHASE1, PHASE2

Find a Study Location Near You

This study is available at 6 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • • TangShan, Hebei
  • • Zhengzhou, Henan
  • • NanChang, Jiangxi
  • • And 3 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Dose-escalation Study Followed by a Dose Optimal Study to Evaluate the Safety and Efficacy of CID-103 in Adults With Chronic Immune Thrombocytopenia - Join Clinical Trial NCTNCT07017725

How to Join This Clinical Trial - NCTNCT07017725

Learn how to participate in this PHASE1, PHASE2 trial studying an investigational therapy for Chronic Immune Thrombocytopenia. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Chronic Immune Thrombocytopenia. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Chronic Immune Thrombocytopenia
Treatment Being Tested
Investigational treatment
Study Phase
PHASE1, PHASE2 - Safety and effectiveness study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT07017725 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 6 locations. Find a study site near you:

Clinical Research Site

TangShan, Hebei 063000 - China

Status: RECRUITING

Clinical Research Site

Zhengzhou, Henan 450000 - China

Status: NOT_YET_RECRUITING

Clinical Research Site

NanChang, Jiangxi 330000 - China

Status: NOT_YET_RECRUITING

Clinical Research Site

Jinan, Shandong 50000 - China

Status: NOT_YET_RECRUITING

Clinical Research Site

TianJin, Tianjin 300000 - China

Status: RECRUITING

Clinical Research Site

Kunming, Yunnan 650000 - China

Status: NOT_YET_RECRUITING

How to Enroll in This Study

To learn more about participating in this PHASE1, PHASE2 clinical trial for Chronic Immune Thrombocytopenia:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai as Your Clinical Trial Matching Service

Quri.ai is a free clinical trial matching service that helps patients connect with research sites. We make it easier to:

  • Find clinical trials that match your condition
  • Get matched to the right study location near you
  • Connect directly with study coordinators
  • Understand if you qualify with simplified eligibility screening
  • Navigate the enrollment process with personalized support
  • Access new treatments through clinical research participation